Next-generation sequencing of formalin-fixed, paraffin-embedded tumor biopsies: Navigating the perils of old and new technology to advance cancer diagnosis

Expert Review of Molecular Diagnostics

Volumn 13, Issue 8, 2013, Pages 769-772

  Latham, Gary J ^a  

^a ASURAGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; PARAFFIN;

CANCER DIAGNOSIS; DNA TEMPLATE; EXOME; FORMALIN FIXED PARAFFIN EMBEDDED TUMOR BIOPSY; GENE DOSAGE; GENE EXPRESSION; GENE SEQUENCE; HUMAN; INDEL MUTATION; NEXT GENERATION SEQUENCING; POINT MUTATION; POLYMERASE CHAIN REACTION; REVIEW; TUMOR BIOPSY;

DNA, NEOPLASM; FORMALDEHYDE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; NEOPLASMS; PARAFFIN EMBEDDING; SEQUENCE ANALYSIS, DNA; TISSUE FIXATION;

EID: 84887360697     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.2013.845090     Document Type: Review

References (23)

1. Blum F. Der formaldehyde als hartungsmittel. Z wiss Mikr 10, 314 (1893
2. Hewitt SM, Lewis FA, Cao Y et al. Tissue handling and specimen preparation in surgical pathology: Issues concerning the recovery of nucleic acids from formalin-fixed, paraffin-embedded tissue. Arch. Pathol. Lab. Med. 132(12), 1929-1935 (2008
3. Staff S, Kujala P, Karhu R et al. Preservation of nucleic acids and tissue morphology in paraffin-embedded clinical samples: Comparison of five molecular fixatives. J. Clin. Pathol. 66(9), 807-810 (2013
4. Freidin MB, Bhudia N, Lim E, Nicholson AG, Cookson WO, Moffatt MF. Impact of collection and storage of lung tumor tissue on whole genome expression profiling. J. Mol. Diagn. 14(2), 140-148 (2012
5. Lander ES. Initial impact of the sequencing of the human genome. Nature 470(7333), 187-197 (2011
6. Wall DP, Tonellato PJ. The future of genomics in pathology. F1000 Med. Rep. 4, 14 (2012
7. Diamandis M, White NM, Yousef GM. Personalized medicine: Marking a new epoch in cancer patient management. Mol. Cancer Res. 8(9), 1175-1187 (2010
8. Bozic I, Reiter JG, Allen B et al. Evolutionary dynamics of cancer in response to targeted combination therapy. eLife 2, e00747 (2013
9. Didelot A, Kotsopoulos SK, Lupo A et al. Multiplex picoliter-droplet digital PCR for quantitative assessment of DNA integrity in clinical samples. Clin. Chem. 59(5), 815-823 (2013
10. Sah S, Chen L, Houghton J et al. Functional DNA quantification guides accurate next-generation sequencing mutation detection in formalin-fixed, paraffin-embedded tumor biopsies. Genome Med. 5(77) (2013
11. DePristo MA, Banks E, Poplin R et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43(5), 491-498 (2011
12. Cibulskis K, Lawrence MS, Carter SL et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31(3), 213-219 (2013
13. Hadd AG, Houghton J, Choudhary A et al. Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens. J. Mol. Diagn. 15(2), 234-247 (2013
14. Singh RR, Patel KP, Routbort MJ et al. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes. J. Mol. Diagn. 15(5), 607-622 (2013
15. Spencer DH, Sehn JK, Abel HJ, Watson MA, Pfeifer JD, Duncavage EJ. Comparison of clinical targeted next-generation sequence data from formalin-fixed and fresh-frozen tissue specimens. J. Mol. Diagn. 15(5), 623-633 (2013
16. Plon SE, Eccles DM, Easton D et al. Sequence variant classification and reporting: Recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum. Mutat. 29(11), 1282-1291 (2008
17. Gargis AS, Kalman L, Berry MW et al. Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat. Biotechnol. 30(11), 1033-1036 (2012
18. van El CG, Cornel MC, Borry P et al. Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics. Eur. J. Human Gene. 21(Suppl. 1), S1-S5 (2013
19. Weiss MM, Van der Zwaag B, Jongbloed JD et al. Best practice guidelines for the use of next-generation sequencing applications in genome diagnostics: A national collaborative study of dutch genome diagnostic laboratories. Hum. Mutat. (2013
20. Rehm HL, Bale SJ, Bayrak-Toydemir P et al. ACMG clinical laboratory standards for next-generation sequencing. Genet. Med. 15(9), 733-747 (2013
21. Schrijver I, Aziz N, Farkas DH et al. Opportunities and challenges associated with clinical diagnostic genome sequencing: A report of the Association for Molecular Pathology. J. Mol. Diagn. 14(6), 525-540 (2012
22. Forshew T, Murtaza M, Parkinson C et al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl. Med. 4(136), 136ra1681 (2012
23. Yost SE, Smith EN, Schwab RB et al. Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens. Nucleic Acids Res. 40(14), e107 (2012